Seattle Children's Hospital, d/b/a Seattle Children's Research Institute

États‑Unis d’Amérique

 
Quantité totale PI 115
Rang # Quantité totale PI 11 309
Note d'activité PI 2,9/5.0    126
Rang # Activité PI 5 465
Parent Seattle Children's Healthcare System

Brevets

Marques

44 0
10 0
61 0
0
 
Dernier brevet 2025 - A4b1 binding aptamers
Premier brevet 1995 - Novel and improved aminoglycosid...

Derniers inventions, produits et services

2024 Invention Bispecific chimeric antigen receptors and therapeutic uses thereof. The invention is directed to...
Invention Vivo gene therapy using intraosseous delivery of a lentiviralgene construct. Methods, compositio...
Invention A4b1 binding aptamers. Various implementations described herein relate to oligonucleotides that ...
Invention Modified vectors. This disclosure relates generally to viral vectors useful for gene therapy appl...
Invention A multi-stage vaccine antigen for malaria. The present disclosure provides a recombinant antigen ...
Invention Asymmetric circular tandem repeat proteins. In certain embodiments, the present invention provide...
Invention Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid del...
Invention Mutant interleukin 15 expressing immune cells. The present disclosure provides methods and artifi...
Invention Inducible programmed cell death-1 (pd1)-cytokine chimera for potentiated immune cell function. Ar...
Invention Therapeutic methods. The invention provides methods for treating a disease associated with SRC Fa...
Invention Proteomic screening for lysosomal storage diseases. Early detection of lysosomal storage disease...
Invention Intein-mediated reconstitution of voltage-gated sodium channel function. Artificial expression co...
Invention Inducible cytokine transgenes for potentiated immune cell function. Artificial expression constru...
Invention Cd62l (l-selectin) aptamer and its application for t cell isolation. Various implementations desc...
2023 Invention N-myristoyltransferase inhibitors and methods of use. Provided herein are compounds of Formula (I...
Invention Cerebral near infrared spectroscopy probe in infants and preterm neonates. An example method incl...
Invention Generating mammalian t cell activation inducible synthetic promoters (syn+pro) to improve t cell ...
Invention Melanocortin and glp-1 receptor agonists and methods of use.
Invention Endotracheal tube having partial wire reinforcement. An endotracheal tube having a bendable port...
Invention Synthetic intermediates for universal chimeric antigen receptor immune cell therapies. Example co...
Invention Variants of coagulation factor viii and uses thereof. Variants of coagulation factor VIII (FVIII)...
Invention Processing images to associate with stages of a surgical procedure. A method includes accessing ...
Invention Oxytocin derivatives and methods of use. Provided herein are compounds of formula (I). In certain...
Invention Homology directed repair compositions for the treatment of hemoglobinopathies. The present discl...
Invention Recombinant receptors binding b cell activation factor receptor and uses thereof. Recombinant rec...
Invention Inhibiting mast cell activation by binding sialic acid-binding immunoglobulin-like lectin-9 (sigl...
Invention Ventilation system. A system includes a container configured to contain a liquid. The system also...
Invention Recombinant proteins that stimulate an immune response in the presence of naturally inhibitory li...
Invention Simplified method of preparing cells for patient administration. The current disclosure describes...
2022 Invention Methods and systems to functionally ablate 3 prime rna ends. Methods and systems to functionally ...
Invention Methods and compositions for modulating the activity of a dimerizing agent regulated immunomodula...
Invention Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof. Hematopoietic...
Invention Sensor paper and methods for use. A sensor paper is infused with bromothymol blue (BTB), a water-...
Invention Compositions incorporating a genetically attenuated plasmodium with modified liver stage nuclear ...
Invention T-cell manufacturing methods. T cell manufacturing methods that co-culture T cells with autologo...
Invention Synthetic nucleic acid elements for enhancing car t cell efficacy. Some embodiments of the metho...
Invention Gene editing for expression of functional factor viii for the treatment of hemophilia. Gene-edit...
Invention Engineering peptides for a a vb6 integrin binding and related methods of use and synthesis. Embo...
Invention Systems and methods for clearing indwelling catheters. Systems, devices, and methods for clearin...
Invention Activity-inducible fusion proteins having a heat shock protein 90 binding domain. Activity-induc...
Invention Hybrid and truncated immune cell proteins. In Hybrid and truncated immune cell proteins are desc...
2021 Invention Immunomodulatory clinical biomarker profiles and uses thereof. The present disclosure relates to...
Invention Diagnostic methods for kawasaki disease. Compositions and methods are provided for diagnosis, pr...
Invention Compositions and methods for targeting plasmodium male gamete protein to block malaria parasite t...
Invention Single-domain antibodies that bind sars-cov-2. Single-domain antibodies that bind the severe acu...
Invention Compositions and methods to reduce neuroinflammation. The use of inhibitors upstream of mTOR in ...
Invention Devices, systems, and methods for automated dissection and processing of biological samples. Sys...
Invention Chimeric antigen receptors (cars) targeting natural killer cells. The current disclosure provide...
Invention Antibodies that specifically bind peptides associated with the primary immunodeficiencies: wiskot...